Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist

Details for Australian Patent Application No. 2008212649 (hide)

Owner AstraZeneca AB Pulmagen Therapeutics (Synergy) Limited

Inventors Wiley, Katherine; Finch, Harry; Dixon, John

Agent Freehills

Pub. Number AU-B-2008212649

PCT Pub. Number WO2008/096126

Priority 0702385.6 07.02.07 GB

Filing date 6 February 2008

Wipo publication date 14 August 2008

Acceptance publication date 19 May 2011

International Classifications

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/096126 Priority application(s): WO2008/096126

21 April 2011 Alteration of Name

  The name of the applicant has been altered to AstraZeneca AB; Pulmagen Therapeutics (Synergy) Limited Amendments

19 May 2011 Application Accepted

  Published as AU-B-2008212649

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008212653-Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

2008212645-2-amin0-5, 7-dihydr0-6Hpyrrolo [3, 4-d] pyrimidine derivatives as HSP-90 inhibitors for treating cancer